AbstractTumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflammation. We have identified a membrane proximal region (aa 218–324) of TNFR1 that restricts surface expression. This was prompted by comparing the dominant-negative properties of a C-terminal truncation of TNFR1 with a point mutant that prevents signalling. C-terminal truncation (aa 218–426) generates a better dominant-negative TNFR1 mutant than inactivation of the death domain by point mutation. The increased dominant-negative activity correlates with increased cell surface expression. The membrane proximal region is the most important region of the receptor for restricting expression
The tumour necrosis factor receptor superfamily (TNFRSF) members contain cysteine-rich domains (CRD)...
INTRODUCTION: Mutations in the TNFRSF1A gene, encoding tumor necrosis factor receptor 1 (TNF-R1), ar...
Introduction: Mutations in the TNFRSF1A gene, encoding tumor necrosis factor receptor 1 (TNF-R1), ar...
Tumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflammation. We...
AbstractTumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflamma...
AbstractTumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point muta...
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in...
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in...
TNF receptor associated periodic syndrome (TRAPS) is an autoinflammatory disease involving recurrent...
Pleiotropic TNF activities are mediated through the two cell surface receptors (TNFRs). Both are tra...
The related TNFR1 studies within the Turner laboratory were funded by Barts and The London Charitabl...
AbstractAutosomal dominant periodic fever syndromes are characterized by unexplained episodes of fev...
Objective: Tumor necrosis factor receptor–associated periodic syndrome (TRAPS) is an autoinflammato...
Objectives: To study the clinical outcome, treatment response, T-cell subsets and functional conseq...
The tumour necrosis factor receptor superfamily (TNFRSF) members contain cysteine-rich domains (CRD)...
INTRODUCTION: Mutations in the TNFRSF1A gene, encoding tumor necrosis factor receptor 1 (TNF-R1), ar...
Introduction: Mutations in the TNFRSF1A gene, encoding tumor necrosis factor receptor 1 (TNF-R1), ar...
Tumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflammation. We...
AbstractTumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflamma...
AbstractTumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point muta...
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in...
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in...
TNF receptor associated periodic syndrome (TRAPS) is an autoinflammatory disease involving recurrent...
Pleiotropic TNF activities are mediated through the two cell surface receptors (TNFRs). Both are tra...
The related TNFR1 studies within the Turner laboratory were funded by Barts and The London Charitabl...
AbstractAutosomal dominant periodic fever syndromes are characterized by unexplained episodes of fev...
Objective: Tumor necrosis factor receptor–associated periodic syndrome (TRAPS) is an autoinflammato...
Objectives: To study the clinical outcome, treatment response, T-cell subsets and functional conseq...
The tumour necrosis factor receptor superfamily (TNFRSF) members contain cysteine-rich domains (CRD)...
INTRODUCTION: Mutations in the TNFRSF1A gene, encoding tumor necrosis factor receptor 1 (TNF-R1), ar...
Introduction: Mutations in the TNFRSF1A gene, encoding tumor necrosis factor receptor 1 (TNF-R1), ar...